Chandra Bhattacharya In The News
Earth.com
A new study reports nanoparticles that send messenger RNA, genetic instructions that tell cells to make proteins, directly to the pancreas with 99 percent selectivity.
PhRMAFoundation
Chandrabali Bhattacharya, PhD, of the University of Nevada, Las Vegas, is developing a platform for in vivo CAR T cell therapy, which could have a tremendous impact on the field of cancer immunotherapy.